BIOMAT Database Logo BIOMAT Database Logo

[Potentiation of the effects of diazoxide by chlorpromazine in the treatment of organic hyperinsulinism]. 1977

P H Vague, and B Vialettes

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002746 Chlorpromazine The prototypical phenothiazine antipsychotic drug. Like the other drugs in this class chlorpromazine's antipsychotic actions are thought to be due to long-term adaptation by the brain to blocking DOPAMINE RECEPTORS. Chlorpromazine has several other actions and therapeutic uses, including as an antiemetic and in the treatment of intractable hiccup. Aminazine,Chlorazine,Chlordelazine,Chlorpromazine Hydrochloride,Contomin,Fenactil,Largactil,Propaphenin,Thorazine,Hydrochloride, Chlorpromazine
D003981 Diazoxide A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group. Hyperstat,Proglycem
D004357 Drug Synergism The action of a drug in promoting or enhancing the effectiveness of another drug. Drug Potentiation,Drug Augmentation,Augmentation, Drug,Augmentations, Drug,Drug Augmentations,Drug Potentiations,Drug Synergisms,Potentiation, Drug,Potentiations, Drug,Synergism, Drug,Synergisms, Drug
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006946 Hyperinsulinism A syndrome with excessively high INSULIN levels in the BLOOD. It may cause HYPOGLYCEMIA. Etiology of hyperinsulinism varies, including hypersecretion of a beta cell tumor (INSULINOMA); autoantibodies against insulin (INSULIN ANTIBODIES); defective insulin receptor (INSULIN RESISTANCE); or overuse of exogenous insulin or HYPOGLYCEMIC AGENTS. Compensatory Hyperinsulinemia,Endogenous Hyperinsulinism,Exogenous Hyperinsulinism,Hyperinsulinemia,Hyperinsulinemia, Compensatory,Hyperinsulinism, Endogenous,Hyperinsulinism, Exogenous

Related Publications

P H Vague, and B Vialettes
[Treatment of organic hyperinsulinism with diazoxide].
November 1979, Vnitrni lekarstvi,
P H Vague, and B Vialettes
Chlorpromazine in the treatment of endogenous organic hyperinsulinism.
June 1974, Diabetologia,
P H Vague, and B Vialettes
Diazoxide for hyperinsulinism.
March 1970, Drug and therapeutics bulletin,
P H Vague, and B Vialettes
Complications of diazoxide treatment in persistent neonatal hyperinsulinism.
October 1989, Archives of disease in childhood,
P H Vague, and B Vialettes
Long-term treatment with diazoxide in childhood hyperinsulinism.
January 1986, Acta endocrinologica. Supplementum,
P H Vague, and B Vialettes
[Treatment of hyperinsulinism with diazoxide over several years].
December 1972, Deutsche medizinische Wochenschrift (1946),
P H Vague, and B Vialettes
Palliative treatment of hyperinsulinism with cyproheptadine and diazoxide.
August 1992, Pediatrics,
P H Vague, and B Vialettes
[Hyperinsulinism treated with diazoxide].
October 1969, Ugeskrift for laeger,
P H Vague, and B Vialettes
HYPERINSULINISM DUE TO METASTASIZING INSULINOMA: TREATMENT WITH DIAZOXIDE.
August 1965, Proceedings of the Royal Society of Medicine,
P H Vague, and B Vialettes
[Continuous treatment with diazoxide of hypoglycemia due to hyperinsulinism].
June 1970, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris,
Copied contents to your clipboard!